October 2020 FDA Recall Childrens Ibuprofen by Aurobindo Pharma Usa Inc.
D-0065-2021 - Labeling Not Elsewhere Classified

This Class III drug recall was voluntarily initiated by Aurobindo Pharma Usa Inc. on October 22, 2020 for the product Childrens Ibuprofen. The FDA reported the reason for recall as labeling not elsewhere classified. The product was distributed in NJ and the recall is currently terminated.

Recall Number: D-0065-2021

Reason for Recall
Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.
Initiated
10-22-2020
Reported
11-11-2020
Quantity
7440 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Aurobindo Pharma USA Inc.
Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever Reducer, 4 fl oz (120 mL), Berry Flavor, Distributed by Chalkboard Health Inc. Princeton, NJ 08540 getfluenthealth.com Made in India. NDC 79395-003-92

Batch or Lot Expiration Information

Lot# BO1020080AA3, EXP 7/2023

Affected Packages Involved in this Recall